CEO of ResMed Inc. (RMD, Financial) Kieran Gallahue sells 30,000 shares of RMD on 12/06/2010 at an average price of $33.15 a share.
Resmed Inc. has a market cap of $5.01 billion; its shares were traded at around $33.13 with a P/E ratio of 24.8 and P/S ratio of 4.6. Resmed Inc. had an annual average earning growth of 16.8% over the past 10 years. GuruFocus rated Resmed Inc. the business predictability rank of 4.5-star.
RMD is in the portfolios of Steven Cohen of SAC Capital Advisors, Jeremy Grantham of GMO LLC.
Resmed Inc. has a market cap of $5.01 billion; its shares were traded at around $33.13 with a P/E ratio of 24.8 and P/S ratio of 4.6. Resmed Inc. had an annual average earning growth of 16.8% over the past 10 years. GuruFocus rated Resmed Inc. the business predictability rank of 4.5-star.
RMD is in the portfolios of Steven Cohen of SAC Capital Advisors, Jeremy Grantham of GMO LLC.
CEO Recent Trades:
- Sell: CEO Kieran Gallahue sold 24,000 shares of RMD stock on 11/10/2010 at the average price of 33.12. Kieran Gallahue owns at least 56,922 shares after this. The price of the stock has increased by 0.03% since.
- Sell: CEO Kieran Gallahue sold 20,000 shares of RMD stock on 09/07/2010 at the average price of 32.38. Kieran Gallahue owns at least 63,590 shares after this. The price of the stock has increased by 2.32% since.
- Sell: CEO Kieran Gallahue sold 20,000 shares of RMD stock on 08/27/2010 at the average price of 60.71. Kieran Gallahue owns at least 31,795 shares after this. The price of the stock has decreased by 45.43% since.
- Sell: CEO Kieran Gallahue sold 20,000 shares of RMD stock on 08/05/2010 at the average price of 33.8. Kieran Gallahue owns at least 3,224 shares after this. The price of the stock has decreased by 1.98% since.
- Sell: CEO Kieran Gallahue sold 10,000 shares of RMD stock on 07/09/2010 at the average price of 32.5. Kieran Gallahue owns at least 3,224 shares after this. The price of the stock has increased by 1.94% since.
CFO Recent Trades:
- Sell: CFO Brett Sandercock sold 20,000 shares of RMD stock on 11/24/2010 at the average price of 32.05. Brett Sandercock owns at least 60,112 shares after this. The price of the stock has increased by 3.37% since.
- Sell: CFO Brett Sandercock sold 6,759 shares of RMD stock on 11/18/2010 at the average price of 33. Brett Sandercock owns at least 60,112 shares after this. The price of the stock has increased by 0.39% since.
- Sell: CFO Brett Sandercock sold 10,000 shares of RMD stock on 11/15/2010 at the average price of 33.59. Brett Sandercock owns at least 66,871 shares after this. The price of the stock has decreased by 1.37% since.
Directors and Officers Recent Trades:
- Sell: Sr. VP, General Counsel David Pendarvis sold 35,000 shares of RMD stock on 11/24/2010 at the average price of 32.53. David Pendarvis owns at least 25,725 shares after this. The price of the stock has increased by 1.84% since.
- Sell: Sr. Vice President, Interfaces Donald Darkin sold 5,332 shares of RMD stock on 11/18/2010 at the average price of 32.72. Donald Darkin owns at least 30,000 shares after this. The price of the stock has increased by 1.25% since.
- Sell: Sr. VP Sleep SBU Michael J. Farrell sold 12,953 shares of RMD stock on 11/12/2010 at the average price of 33.7. Michael J. Farrell owns at least 16,891 shares after this. The price of the stock has decreased by 1.69% since.
- Sell: COO, Europe Stein Jacobsen sold 87,722 shares of RMD stock on 11/12/2010 at the average price of 33.23. Stein Jacobsen owns at least 30,001 shares after this. The price of the stock has decreased by 0.3% since.
- Sell: COO Asia Pacific Robert Andrew Douglas sold 20,000 shares of RMD stock on 11/12/2010 at the average price of 33.51. Robert Andrew Douglas owns at least 34,757 shares after this. The price of the stock has decreased by 1.13% since.
